Genetic Testing for Cancer
Summit Medical Group is partnering with Ambry Genetics, a leader in clinical and diagnostic testing, to utilize the Ambry CARE ProgramTM to identify patients at a higher risk of developing cancer.
Only a small fraction of people with a hereditary predisposition to cancer are aware of that fact and are tested. Genetic testing for hereditary cancer risk can help patients be proactive about their health care and make decisions with their care team on preventative surgeries, cancer screenings, and targeted cancer therapies. The Ambry CARE ProgramTM allows us to arm our patients with information to understand their risk and treatment options.
What is Genetic Testing?
Only a small fraction of people with a hereditary predisposition to cancer are aware of that fact and are tested. Genetic testing for hereditary cancer risk can help patients be proactive about their health care and make decisions with their care team on preventative surgeries, cancer screenings, and targeted cancer therapies. The Ambry CARE ProgramTM allows us to arm our patients with information to understand their risk and treatment options.
Who Can Benefit and How?
The Ambry CARE ProgramTM is not limited to a single type of cancer. Results of genetic testing can help determine if someone has a higher risk of developing a wide range of cancers, including breast (men and women), ovarian, colorectal, uterine, pancreatic, prostate, stomach and melanoma, among others. A patient's personal and family history provides critical information to help providers manage cancer risks through screening and prevention strategies. These provide your physician with the information she or he requires to advise you on appropriate treatment decisions.
According to national guidelines, women with an increased risk for breast cancer should consider earlier and/or more frequent breast cancer screenings via mammograms, and in some situations, with breast MRI/contrast-enhanced mammography.
Genetic Testing: The Patient Experience
Watch this short video to see how the testing process works, from beginning to end - and see if this is something you should speak to your doctor about.
Ambry Genetics, a subsidiary of REALM IDx, Inc., translates scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind genetic diseases. It is a leader in genetic testing that aims to improve health by understanding the relationship between genetics and diseases. Due to its unparalleled track record of discoveries over 20 years, as well as to its growing database that continues to expand in collaboration with academic, corporate and pharmaceutical partners, Ambry Genetics is first to market with innovative products and comprehensive analysis that enable clinicians to confidently inform patient health decisions. For more information, please visit ambrygen.com.